ABSTRACT
@#Abstract: 【Objective】To study the effects of notoginsenoside R1 on the levels of intercellular adhesion molecule- 1（ICAM- 1），tumor necrosis factor- α （TNF- α），metalloproteinase- 2 （MMP- 2） and metalloproteinase- 2 inhibitor （TIMP- 2）in rats with atrial fibrillation in order to explore the mechanism of notoginsenoside R1 on the preventing and treating atrial fibrillation. 【Methods】 102 rats were randomly divided into control group ，atrial fibrillation group and notoginsenoside R1 group，with 34 rats in each group. The rat model of atrial fibrillation was established by injection of acetylcholine-calcium chloride into the tail vein. The rats in the notoginsenoside R1 group were intraperitoneally injected with 2 mL of notoginsenoside R1. ECG was used to measure the duration of atrial fibrillation. Masson staining was used to observe the degree of myocardial fibrosis. Immunohistochemistry was used to detect the expression of MMP-2 and TIMP-2 in atrial tissue. The serum ICAM-1，TNF-α，MMP-2 and TIMP-2 levels were determined by enzyme-linked immunosorbent assay（ELISA）. The levels of ICAM-1，TNF-α and type I collagen in atrial tissue were determined by Western blotting.【Results】Before the treatment of notoginsenoside R1 ，there was no significant difference in the duration of atrial fibrillation between the two groups（P > 0.05）. After treatment，the duration of atrial fibrillation in the notoginsenoside R1 group［（6.37±2.02）s］was lower than that in the pre-treatment and the atrial fibrillation groups（P < 0.05）. Masson staining showed：the amount of atrial fibrillar collagen fibers in control group was normal；a large number of collagen fibers were seen in the atrial myocytes of atrial fibrillation group；the patchy and punctate collagen fibers were seen in the atrial myocytes of notoginsenoside R1 group. Compared with control group，the serum levels of ICAM-1，TNF- α and MMP-2 ［（137.52±16.59）10-6 g/L，（14.25±1.08）10-6 g/L，（435.26±17.63）10-9 g/L；（109.25±14.62）10-6 g/L ，（12.31±1.27）10-6 g/L， （288.47±15.52）10-9 g/L］were increased（P < 0.05），the serum levels of TIMP-2 levels［（3 541.27±331.24）10-9 g/L ； （3 975.46 ± 313.24）10- 9 g/L］was decreased（P < 0.05），the atrial tissue ICAM- 1，TNF- α and type I collagen levels （0.23±0.07 ，0.51±0.09 、0.63±0.14 ；0.15±0.06 ，0.22±0.07 ，0.27±0.12）were increased（P < 0.05），the atrial tissue MMP-2 protein optical density（0.35±0.07；0.18±0.06）was increased（P < 0.05），the atrial tissue TIMP-2 protein optical density（0.11±0.04；0.18±0.03）was decreased（P < 0.05）in atrial fibrillation group and the notoginsenoside R1 group； Compared with atrial fibrillation group，the levels of serum ICAM-1，TNF- α and MMP-2 were decreased（P < 0.05）， the levels of serum TIMP-2 was increased（P < 0.05），the atrial tissue ICAM- 1 ，TNF- α and type I collagen levels were decreased（P < 0.05），the density of MMP-2 protein in atrial tissue was decreased（P < 0.05），and the optical density of TIMP-2 protein in atrial tissue was increased（P < 0.05）in the rats in notoginsenoside R1 group.【Conclusion】 Notoginsenoside R1 can prevent and treat atrial fibrillation by reducing the levels of ICAM- 1，TNF- α and MMP-2 and increasing the levels of TIMP-2 in serum and atrial tissue of rats with atrial fibrillation.
ABSTRACT
Objective :To explore changes of plasma levels of BNP and copeptin (CPT) in patients with chronic heart failure (CHF) of different degrees and their correlation with cardiac function class .Methods :A total of 150 CHF patients treated in our hospital from Feb 2015 to Feb 2017 ,were selected as CHF group .Another 45 healthy volun‐ teers undergoing physical examination in our hospital simultaneously were regarded as healthy control group .Plasma BNP and CPT levels were compared between two groups .According to NYHA cardiac function class ,CHF group was further divided into class II group (n＝48) ,class III group (n＝51) and class IV group (n＝51).Plasma levels of BNP and CPT etc .were measured and compared among three subgroups .Correlation among BNP ,CPT levels and cardiac function class were analyzed in CHF patients .Results :Compared with healthy control group ,there were significant rise in plasma levels of BNP and CPT in CHF group , P＝ 0.001 both .Compared with class II group , there were significant rise in plasma levels of BNP [ (1002.82 ± 101.33) pmol／L vs.(1515.05 ± 166.73) pmol／L vs.(2102.36 ± 227.32) pmol／L] ,CPT [ (6.51 ± 1.01 ) pmol／L vs.(9.28 ± 2.89 ) pmol／L vs .(14.03 ± 3.72 ) pmol／L] and LVEDd [ (51.51 ± 4. 01) mm vs.(59.28 ± 6.19) mm vs.(64. 03 ± 5.72) mm] ,and significant reduc‐tion in LVEF [ (50. 82 ± 6. 33)% vs.(45.05 ± 4.73)% vs.(41.36 ± 2.32)%] in class III group and class IV group , and plasma levels of BNP ,CPT ,LVEDd in class IV group were significantly higher than those of class III group , and LVEF was significantly lower than that of class III group , P＝0. 001 all.Spearman correlation analysis indicated that plasma levels of BNP and CPT were significant positively correlated with cardiac function class in CHF patients ( r＝0.320 ,0.302 , P＝0.009 ,0.011).Conclusion :Along with CHF aggravates ,the plasma levels of BNP and CPT significantly rise .Cardiac function class is significant positively correlated with plasma levels of BNP and CPT .
ABSTRACT
<p><b>BACKGROUND</b>Malnutrition and tuberculosis (TB) tend to interact with each other. TB may lead to nutrition deficiencies that will conversely delay recovery by depressing immune functions. Nutrition support can promote recovery in the subject being treated for TB. The aim of this study was to evaluate the effectiveness of nutrition support on promoting the recovery of adult pulmonary TB patients with anti-TB drug therapy.</p><p><b>METHODS</b>English database of the Cochrane Controlled Trials Register, PubMed, EMBASE, and Chinese database of CBM, CNKI, VIP, and WANFANG were searched. Randomized controlled trials comparing nutrition support (given for more than 2 weeks) with no nutrition intervention, nutrition advice only, or placebo-control for TB patients being anti-TB treated were included. Two reviewers conducted data extraction, assessed the quality of the studies independently, and any discrepancies were solved by the third reviewer. Data were entered and analyzed by RevMan 5.2 software, and meta-analysis was done using risk ratios (RR s) for dichotomous variables and mean differences (MDs) for continuous variables with 95% confidence intervals (CI s).</p><p><b>RESULTS</b>A total of 19 studies (3681 participants) were included. In nutritional support for TB patients, pooled RR and its 95% CI of sputum smears- or culture-negative conversion rate and chest X-ray (CXR) absorption rate were 1.10 (1.04, 1.17) and 1.22 (1.08, 1.39), respectively, the pooled MD and its 95% CI of body mass index (BMI) and time of sputum smears or culture negativity were 0.59 (0.16, 1.2) and - 5.42 (-7.93, -2.92), respectively, compared with the control group. The differences in outcomes of CXR zone affected, TB score, serum albumin, and hemoglobin were not statistically significant (P = 0.76, 0.24, 0.28, and 0.20, respectively) between the intervention group and the control group. No systemic adverse events were recorded.</p><p><b>CONCLUSIONS</b>During anti-TB course, nutrition support may be helpful in treatment of TB patients by improving both sputum smears- or culture-negative conversion rate and BMI, shortening the time of sputum conversion negative. Whether it can improve the final clinical effect, there still needs high-level quality studies to confirm in the future.</p>